Table 1.
Product design parameters for manufacturing LNG-IUSs*.
| No. | LNG-IUSs with different drug loading | Comments |
|---|---|---|
| 1 | 0.5% w/w DL | Drug loading ranging from 0.5% w/w to 50% w/w was used to investigate the impact on drug release characteristics. 50% w/w drug loading was used as a reference. |
| 2 | 1% w/w DL | |
| 3 | 2.5% w/w DL-T* | |
| 4 | 2.5% w/w DL-C* | |
| 5 | 5% w/w DL | |
| 6 | 10% w/w DL | |
| 7 | 25% w/w DL | |
| 8 | 50% w/w DL | |
| 9 | 48.8% w/w DL | 5% more in excipient amount |
| 10 | 51.1% w/w DL | 5% less in excipient amount |
| 11 | 47.6% w/w DL | 10% more in excipient amount |
| 12 | 52.6% w/w DL | 10% less in excipient amount |
T and C represent the API obtained from Tecoland and Cayman, respectively. API from Tecoland was used in the formulations without T or C.